Details

NameSymbolSector
NOVELIX PHARMACEUTICALS LIMITEDNOVELIXPharmacy Retail
Open
56.5
High
57.55
Low
55.3
Close
55.53
Volume
930
Exchange
bse
Time
28-Apr-2026

Outlook

Score:  

1.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Novelix Pharmaceuticals is  
Short Body
Estimated Stoploss of Novelix Pharmaceuticals is ₹  
57.55
Novelix Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Short Body
 candle pattern indicates the trend direction of Novelix Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Novelix Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Novelix Pharmaceuticals is  
Downℹ
 by  

1.28

%. 
Target
Buy @ 

50.32

Sell @ 

64.98

Current @ 

55.53

Volume

The trade volumes of Novelix Pharmaceuticals have become  
Deficientℹ
The volume trend for Novelix Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Novelix Pharmaceuticals is  

Down

 by  

86.3

% 

Valuation

The current market price of Novelix Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 27cr and total assets worth ₹ 27cr, the balance sheet of Novelix Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Novelix Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 13cr spent in operatingℹ
7.69% i.e. ₹ 2cr earned in investingℹ
42.31% i.e. ₹ 11cr earned in financingℹ
0% in otherℹ
Income
The income of Novelix Pharmaceuticals is  

₹ 22cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

10

% 

(*Jun 2025)

The income of Novelix Pharmaceuticals is  

₹ 20cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

300

% 

(*Mar 2025)

The income of Novelix Pharmaceuticals is  

₹ 5cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

66.67

% 

(*Dec 2024)

Market Cap

Market capital of NOVELIX PHARMACEUTICALS LIMITED is 85cr

Top Rated Competitors

NameScore
Medplus Health Services Limited
0
By using this site you agree to the use of cookies to deliver a better site experience.